The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

37 articles for V Summa


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a Selective Series of Inhibitors of Plasmodium falciparum HDACs.EBI
Irbm Science Park
Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors.EBI
Istituto Di Ricerche Di Biologia Molecolare &Quot;P. Angeletti
Methyl-Transferase-Like Protein 16 (METTL16): The Intriguing Journey of a Key Epitranscriptomic Player Becoming an Emerging Biological Target.EBI
University of Naples Federico II
Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination.EBI
University of Naples Federico Ii
Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors.EBI
P. Angeletti S.P.A. (Merck Research Laboratories)
Easy access to α-ketoamides as SARS-CoV-2 and MERS MEBI
University of Naples Federico Ii
Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides.EBI
IRBM Science Park
Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant.EBI
Mrl Rome
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.EBI
University of Naples "Federico Ii
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.EBI
University of Naples "Federico Ii
Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents.EBI
Promidis
Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators.EBI
Promidis
HCV NS5b RNA-dependent RNA polymerase inhibitors: from alpha,gamma-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5-hydroxypyrimidinonecarboxylic acids. Design and synthesis.EBI
Italy. Vinc
The monoethyl ester of meconic acid is an active site inhibitor of HCV NS5B RNA-dependent RNA polymerase.EBI
Mrl Rome
Discovery of alpha,gamma-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase.EBI
Italy. Vinc
Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction.EBI
Irbm
Discovery of 4-((1-(1H-imidazol-2-yl)alkoxy)methyl)pyridines as a new class of Trypanosoma cruzi growth inhibitors.EBI
Irbm
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein.EBI
Irbm
Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction.EBI
Irbm
Design, Synthesis, and Biological Evaluation of New 1-(Aryl-1 H-pyrrolyl)(phenyl)methyl-1 H-imidazole Derivatives as Antiprotozoal Agents.EBI
"Sapienza" Universit£
Identification of Isoform 2 Acid-Sensing Ion Channel Inhibitors as Tool Compounds for Target Validation Studies in CNS.EBI
Promidis
Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.EBI
Irbm Science Park
Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2-P4 linkers.EBI
Merck Research Laboratories
Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor.EBI
Merck Research Laboratories
Development of 2-pyrrolidinyl-N-methyl pyrimidones as potent and orally bioavailable HIV integrase inhibitors.EBI
Irbm-Mrl
Dihydroxy-pyrimidine and N-methylpyrimidone HIV-integrase inhibitors: improving cell based activity by the quaternarization of a chiral center.EBI
Irbm-Merck Research Laboratories Rome
N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors.EBI
Irbm-Mrl
3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates--a new class of HIV-1 integrase inhibitors.EBI
Merck Research Laboratories Rome
4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.EBI
Irbm-Mrl Rome
Development of 2-t butyl-N-methyl pyrimidones as potent inhibitors of HIV integrase.EBI
Irbm-Mrl Rome
From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors: SAR around the amide moiety.EBI
Irbm-Mrl Rome
Heterocycle derivatives having TrkA inhibitory activityBDB
Shionogi
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseasesBDB
Takeda Pharmaceutical
1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent aurora kinase inhibitor with a favorable antitumor kinase inhibition profile.BDB
Nerviano Medical Sciences
Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties.BDB
Instituto De Quimica Medica (Csic)
SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.BDB
University of Bologna
Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.BDB
Shanghai Institute of Materia Medica